1. Audit of general practitioner referrals for erectile dysfunction within north central london
- Author
-
Parth Tagdiwala, Ali Pasyar, Don Lee, and Matthew Megson
- Subjects
Medicine - Abstract
Background/Introduction: General practitioners (GPs) referring patients with Erectile Dysfunction (ED) to North Central London (NCL) secondary care urology services must comply with the Erectile Dysfunction Referral Pathway (EDRP). The EDRP requires GPs to provide a detailed patient history, conduct specific blood tests, offer psychological support and attempt certain medical treatments prior to referral.We aim to identify all new patients referred by GPs for ED at two NCL trusts and assess compliance to the EDRP; Royal Free London (RFL) and University College London Hospital (UCLH) foundation trusts. Patients and methods: A retrospective review of the electronic patient care record was undertaken between the dates 11 January 2018 and 31 January 2022. Patients who had been directly referred for ED from primary care were identified, any incomplete records were excluded. Using a non-validated questionnaire, we collected the following data points from referral letters: patient background, date of referral, Peyronie's disease presence, completeness of patient history, treatment(s) attempted. Results: N=445 ED referrals were identified, n=364 were not primary care referrals thus excluded. n=81 patients were direct referrals; n=17 and n=64 patient to RFL and UCLH respectively.Patient history was reported as follows: Peyronies disease (n=72), sexual history (n=47), performance status (n=80), medications (n=40), Performance achieving/maintaining erections or both (n=44), hypertension (n=59), BMI (n=29) and smoking status (n=60).Blood tests reported; testosterone levels (n=26), TFTs (n=26), HbA1c/fasting glucose (n=37), lipid profile (n=37) and urine/electrolytes (n=39).Treatments trialed by GP: sildenafil (n=36), tadalafil (n=17), both sildenafil and tadalafil (n=10), neither sildenafil nor tadalafil or unclear (n=11) and contraindication to PDE5 inhibitor (n=3). Discussion/Conclusion: It is evident GPs do not provide complete patient history, nor exhaust all treatment options, nor organise blood tests prior to referral. We suggest the creation of a proforma and educating GPs on the importance of utilising the proforma to deliver more efficient care.
- Published
- 2024
- Full Text
- View/download PDF